The granted claims cover novel phenoxyphenyl acetic acid compounds newly, their formulation and uses in Prostaglandin D2 -dependent circumstances.. Amira announces UK patent grant for heteroalkyl antagonists of prostaglandin D2 receptors Amira Pharmaceuticals, Inc. Today announced that the U.K. Intellectual Property Workplace has granted patent quantity GB2461629, titled, HETEROALKYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS, which include protection of Amira’s AM461 DP2 receptor antagonist. This is actually the second patent granted of a big estate filed by Amira Pharmaceuticals that describe novel small molecule inhibitors of the DP2 receptor.The analysis was funded by the German Study Base and the RUB’s Rectorate program.
Canada announces new HIV/AIDS funding of $84.4 million annually. In the 1st year, funding shall be targeted to support community-based organizations dealing with populations most at risk of infection. THE FEDERAL GOVERNMENT of Canada remains focused on fighting HIV/AIDS, said Minister Pettigrew. This funding will build on the achievement of the CSHA by strengthening communities to combat the illnesses and the stigma and discrimination that fuels their spread. Related StoriesSafe, effective douche-centered rectal microbicide can prevent HIV in gay menResearch provides qualified prospects for new strategies to develop HIV vaccineNew initiative released to accelerate search for effective HIV vaccinePartnerships with provinces, territories and stakeholders and the international community shall continue to be necessary to the success of this approach.